Clinical Trial Update: Study of INV-202 in Patients With Obesity and Metabolic Syndrome [Phase 2]

View source ↗

Summary

Phase 2 study of INV-202 in obesity and metabolic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Obesity

Drugs mentioned

• INV-202

Snippet

Sponsor: Inversago Pharma Inc. | Conditions: Obesity, Metabolic Syndrome | Phase 2 | Status: COMPLETED